Across TCGA patient cohorts, BCL9L RNA expression is significantly associated with the protein abundance of many other proteins, with 8,675 significant associations in total. LUAD shows the largest number of these associations.

The most reproducible BCL9L-associated proteins across cancer lineages are PXN, PARD3_S383, and HID1. Each is linked with BCL9L in more than 3 cancer types. Because this analysis shows association rather than direction, both BCL9L-to-partner and partner-to-BCL9L results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (BCL9L→partner) and Y-score (partner→BCL9L) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LSCC	PXN →	+0.276	+0.407	<.001	.008	3	4
LUAD	PARD3_S383 →	-0.523	-0.485	<.001	.002	3	3
COAD	HID1 →	-0.331	-0.757	.008	.006	3	3
PDAC	MPRIP_S301 →	-0.600	-0.476	<.001	<.001	3	3
PDAC	EMC1 →	-0.250	-0.540	<.001	<.001	3	3
PDAC	ANXA2_S127 →	+0.763	+0.334	.003	.001	3	3

Each partner links to its Q-omics profile. Showing the 6 strongest of 8,675 associations by consensus.

Exploration

BCL9L survival (RNA) · tumor vs normal (RNA) · all BCL9L data types